GlassScriptPhysician profile
Sandra M Gutierrez
NPI 1912908187
$2,449.64
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,789 · 2020: $416 · 2021: $115 · 2022: $129.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $374.69 | 2019-2022 | |
| Amgen INC. | $292.90 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $217.13 | 2019 | |
| Mallinckrodt Enterprises LLC | $210.24 | 2019 | |
| Daiichi Sankyo INC. | $209.34 | 2019 | |
| Boston Scientific Corporation | $163.94 | 2019-2020 | |
| Mdd US Operations, LLC | $148.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $124.68 | 2019 | |
| Scilex Pharmaceuticals INC. | $113.79 | 2019 | |
| Biogen, INC. | $87.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.27 | 2019 | |
| Pfizer INC. | $56.05 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $49.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.90 | 2019 | |
| Vertical Pharmaceuticals, LLC | $37.59 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Promius Pharma LLC | $36.70 | 2019 | |
| Collegium Pharmaceutical, INC. | $27.57 | 2019-2020 | |
| Assertio Therapeutics, INC. | $26.96 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $26.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.62 | 2019 | |
| Biodelivery Sciences International, INC. | $24.62 | 2019-2020 | |
| Pacira Therapeutics, INC. | $21.36 | 2019 | |
| Abbott Laboratories | $21.25 | 2020 | |
| Zyla Life Sciences, INC. | $14.16 | 2020 | |
| Shionogi INC | $11.27 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.